SPN and leukemia: R54high or B2high MLL/AF9-OVA leukemia cells preferentially survived in vivo in the presence of adaptive immune cells, suggesting that glycosylation status of CD43 on leukemia cells is associated with selection of leukemia cells by immune surveillance in vivo.